Which pre-procedure tests assess bleeding risk prior to invasive procedures, and what is a common threshold?

• A. Platelet count alone determines bleeding risk; thresholds are fixed at 100,000.
• B. Serum creatinine is the only test used.
• C. Bleeding risk is assessed by liver function tests only.
• D. Platelet count and coagulation tests (PT/INR, aPTT) thresholds vary, with commonly >50,000 platelets per μL for many procedures.

Answer: (D)

Bleeding risk before invasive procedures is best assessed by evaluating both platelets and the coagulation cascade. Platelets handle primary hemostasis by forming the initial plug, while tests like PT/INR and aPTT assess secondary hemostasis by measuring clotting factors in the cascade. Because the risk varies by how invasive the procedure is, there isn’t a single fixed threshold; however, a common practical standard is that having more than about 50,000 platelets per microliter is considered adequate for many procedures, with higher thresholds for more invasive or high-risk interventions. Serum creatinine alone does not gauge bleeding risk, and liver function tests alone don’t directly quantify it, though severe liver dysfunction can affect coagulation. Using both platelet count and coagulation studies provides the most reliable assessment of bleeding risk.